Table 2. The quality assessment of included studies based on the Cochrane handbook.
Study | A | B | C | D | E | F | G | Total |
---|---|---|---|---|---|---|---|---|
Massie (1999) | ? | ? | + | ? | + | + | + | 4 |
Neill (2003) | ? | ? | + | + | + | + | + | 4 |
Mador (2005) | + | ? | - | ? | + | + | + | 4 |
Salgado (2008) | ? | ? | - | - | + | + | + | 3 |
Ryan (2009) | ? | ? | + | + | + | + | + | 4 |
Worsnop (2010) | ? | ? | + | + | + | - | + | 3 |
Ruhle(2011) | ? | ? | ? | ? | + | + | + | 3 |
Soudorn(2016) | ? | ? | + | ? | + | + | + | 4 |
Nilius(2016) | ? | ? | + | ? | + | + | + | 4 |
A = sequence generation; B = allocation concealment; C = blinding of participants and personnel; D = blinding of outcome assessment; E = incomplete outcome data; F = selective outcome reporting; G = other sources of bias; + = Yes;— = No; ? = unclear (‘Yes’ for a low risk of bias, ‘No’ for a high risk of bias; ‘Unclear’ otherwise)